Items tagged with Medicines
WHO suspends TB drugs from big India supplier on quality fears (post)
March 18, 2016 - The World Health Organization has suspended the approval of tuberculosis drugs made by India's Svizera Labs, a major supplier to developing countries, following an investigation into standards.
New fixed-dose paediatric TB formulations now available for procurement through the Global Drug Facility (post)
31 March 2016 – Geneva, Switzerland - The new fixed-dose paediatric formulations are now available for procurement through the Global Drug Facility (GDF): rifampicin 75 mg + isoniazid 50 mg + pyrazinamide 150 mg and rifampicin 75 mg + isoniazid 50. The products dissolve in water, have a fruit flavour, and are simple to administer.
Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial (post)
Abstract
Tuberculosis drug may also target visceral leishmaniasis (post)
A drug that has already been approved for treatment of tuberculosis could also be a powerful tool to combat another of the developing world’s major diseases, researchers at the University of Dundee have found.
TB Treatment Trials Grid 2016 (post)
Michael Vjecha, MD compiled for the Tuberculosis Trials Consortium (TBTC) a table containing information about the planned, ongoing, and recently completed randomized TB drug clinical trials.
Modeling the correct doses for disease-fighting drugs (post)
In treating diseases with drugs, dosing is critical; too little is ineffective, while too much can be lethal. Colorado State University’s Brad Reisfeld takes a mathematical approach to achieving optimal dosing for various drugs.
Research hones in on new TB drugs (post)
University of Queensland (UQ) scientists are honing in on drug-resistant tuberculosis (TB), in a project which could lead to new antibiotics.
Penn State, TB Alliance, and GSK partner to discover new treatments for TB (post)
UNIVERSITY PARK, Pa., June 27, 2016 -- A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Researchers receive $9 million grant to fast track the discovery of new antibiotics (post)
In September 2014, President Obama issued an executive order for “Combating Antibiotic-Resistant Bacteria.” Why the urgency? The Centers for Disease Control and Prevention, the order noted, “estimates that annually at least 2 million illnesses and 23,000 deaths are caused by antibiotic-resistant bacteria in the United States alone.”
No time to wait: Lack of funding for TB drug research threatens projects (post)
Research into desperately needed new tuberculosis (TB) drugs is flagging because governments and pharmaceutical companies are not investing enough in the field, scientists warned on the eve of the 21st International AIDS conference, which begins on Monday (July 18).
Page 4 of 19 · Total posts: 0
←First 3 4 5 Last→